Comparison of [18F]FDG PET/CT with magnetic resonance imaging for the assessment of human brown adipose tissue activity

被引:10
|
作者
Fischer, Jonas Gabriel William [1 ,2 ]
Maushart, Claudia Irene [1 ,2 ]
Becker, Anton S. [3 ]
Mueller, Julian [4 ]
Madoerin, Philipp [5 ]
Chirindel, Alin [6 ]
Wild, Damian [6 ]
ter Voert, Edwin E. G. W. [4 ]
Bieri, Oliver [2 ,7 ]
Burger, Irene [4 ]
Betz, Matthias Johannes [1 ,2 ]
机构
[1] Univ Hosp Basel, Dept Endocrinol Diabet & Metab, Petersgraben 4, CH-4031 Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Ramistr 100, CH-8091 Zurich, Switzerland
[4] Univ Hosp Zurich, Dept Nucl Med, Ramistr 100, CH-8091 Zurich, Switzerland
[5] Univ Hosp Basel, Dept Radiol, Div Radiol Phys, Basel, Switzerland
[6] Univ Hosp Basel, Div Nucl Med, Petersgraben 4, CH-4031 Basel, Switzerland
[7] Univ Hosp Basel, Dept Radiol, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
FAT-FRACTION; WHITE; MRI; THERMOGENESIS; MECHANISM;
D O I
10.1186/s13550-020-00665-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Brown adipose tissue (BAT) is a thermogenic tissue which can generate heat in response to mild cold exposure. As it constitutes a promising target in the fight against obesity, we need reliable techniques to quantify its activity in response to therapeutic interventions. The current standard for the quantification of BAT activity is [F-18]FDG PET/CT. Various sequences in magnetic resonance imaging (MRI), including those measuring its relative fat content (fat fraction), have been proposed and evaluated in small proof-of-principle studies, showing diverging results. Here, we systematically compare the predictive value of adipose tissue fat fraction measured by MRI to the results of [F-18]FDG PET/CT. Methods: We analyzed the diagnostic reliability of MRI measured fat fraction (FF) for the estimation of human BAT activity in two cohorts of healthy volunteers participating in two prospective clinical trials (NCT03189511, NCT03269747). In both cohorts, BAT activity was stimulated by mild cold exposure. In cohort 1, we performed [F-18]FDG PET/MRI; in cohort 2, we used [F-18]FDG PET/CT followed by MRI. Fat fraction was determined by 2-point Dixon and 6-point Dixon measurement, respectively. Fat fraction values were compared to SUVmean in the corresponding tissue depot by simple linear regression. Results: In total, 33 male participants with a mean age of 23.9 years and a mean BMI of 22.8 kg/m(2) were recruited. In 32 participants, active BAT was visible. On an intra-individual level, FF was significantly lower in high-SUV areas compared to low-SUV areas (cohort 1: p < 0.0001 and cohort 2: p = 0.0002). The FF of the supraclavicular adipose tissue depot was inversely related to its metabolic activity (SUVmean) in both cohorts (cohort 1: R-2 = 0.18,p = 0.09 and cohort 2: R-2 = 0.42, p = 0.009). Conclusion: MRI FF explains only about 40% of the variation in BAT glucose uptake. Thus, it can currently not be used to substitute [F-18] FDG PET-based imaging for quantification of BAT activity.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Melatonin deficiency decreases brown adipose tissue acute thermogenic capacity of in rats measured by 18F-FDG PET
    Halpern, Bruno
    Mancini, Marcio C.
    Mendes, Caroline
    Machado, Camila Maria Longo
    Prando, Silvana
    Sapienza, Marcelo Tatit
    Buchpiguel, Carlos Alberto
    do Amaral, Fernanda Gaspar
    Cipolla-Neto, Jose
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01):
  • [32] The Added Value of [18F]FDG PET/CT in the Management of Invasive Fungal Infections
    Ankrah, Alfred O.
    Creemers-Schild, Dina
    de Keizer, Bart
    Klein, Hans C.
    Dierckx, Rudi A. J. O.
    Kwee, Thomas C.
    Span, Lambert F. R.
    de Jong, Pim A.
    Sathekge, Mike M.
    Glaudemans, Andor W. J. M.
    DIAGNOSTICS, 2021, 11 (01)
  • [33] Diffusion-weighted MR imaging in comparison to integrated [18F]-FDG PET/CT for N-staging in patients with lung cancer
    Pauls, Sandra
    Schmidt, Stefan A.
    Juchems, Markus S.
    Klass, Oliver
    Luster, Markus
    Reske, Sven Norbert
    Brambs, Hans-Juergen
    Feuerlein, Sebastian
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (01) : 178 - 182
  • [34] Benefit of [18F]-FDG PET/CT for treatment-naive nasopharyngeal carcinoma
    Yang, Shan-Shan
    Wu, Yi-Shan
    Chen, Wei-Chao
    Zhang, Jun
    Xiao, Su-Ming
    Zhang, Bao-Yu
    Liu, Zhi-Qiao
    Chen, En-Ni
    Zhang, Xu
    Ouyang, Pu-Yun
    Xie, Fang-Yun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (03) : 980 - 991
  • [35] Gender differences in brown adipose tissue-related brain functional networks: an 18F-FDG-PET study
    Shao, Xiaoliang
    Chen, Yuqi
    Shao, Xiaonan
    Wang, Suhong
    Wang, Suwen
    Wang, Yuetao
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (06) : 526 - 532
  • [36] A Comparison of 18F-FDG-PET/MRI and 18F-FDG-PET/CT in the Cancer Staging of Locoregional Lymph Nodes
    Slouka, David
    Krcal, Jiri
    Kostlivy, Tomas
    Hrabacka, Petr
    Skalova, Alena
    Mirka, Hynek
    Topolcan, Ondrej
    Kucera, Radek
    IN VIVO, 2020, 34 (04): : 2029 - 2032
  • [37] Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI
    Bernhard Daniel Klumpp
    Nina Schwenzer
    Philip Aschoff
    Stephan Miller
    Ulrich Kramer
    Claus D. Claussen
    Bjoern Bruecher
    Alfred Koenigsrainer
    Christina Pfannenberg
    Abdominal Imaging, 2013, 38 : 64 - 71
  • [38] Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma
    Jiang, Lei
    Tan, Hui
    Panje, Cedric M.
    Yu, Haojun
    Xiu, Yan
    Shi, Hongcheng
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (01) : 1 - 7
  • [39] Chordoma: 18F-FDG PET/CT and MRI imaging features
    Olson, Joshua T.
    Wenger, Doris E.
    Rose, Peter S.
    Petersen, Ivy A.
    Broski, Stephen M.
    SKELETAL RADIOLOGY, 2021, 50 (08) : 1657 - 1666
  • [40] F-18 FDG PET-CT imaging of a mycotic aneurysm
    Davison, JM
    Montilla-Soler, JL
    Broussard, E
    Wilson, R
    Cap, A
    Allen, T
    CLINICAL NUCLEAR MEDICINE, 2005, 30 (07) : 483 - 487